Rhinovirus induction of fractalkine (CX3CL1) in airway and peripheral blood mononuclear cells in asthma

Rhinovirus infection is associated with the majority of asthma exacerbations. The role of fractalkine in anti-viral (type 1) and pathogenic (type 2) responses to rhinovirus infection in allergic asthma is unknown. To determine whether (1) fractalkine is produced in airway cells and in peripheral blood leucocytes, (2) rhinovirus infection increases production of fractalkine and (3) levels of fractalkine differ in asthmatic compared to non-asthmatic subjects. Fractalkine protein and mRNA levels were measured in bronchoalveolar lavage (BAL) cells and peripheral blood mononuclear cells (PBMCs) from non-asthmatic controls (n = 15) and mild allergic asthmatic (n = 15) subjects. Protein levels of fractalkine were also measured in macrophages polarised ex vivo to give M1 (type 1) and M2 (type 2) macrophages and in BAL fluid obtained from mild (n = 11) and moderate (n = 14) allergic asthmatic and non-asthmatic control (n = 10) subjects pre and post in vivo rhinovirus infection. BAL cells produced significantly greater levels of fractalkine than PBMCs. Rhinovirus infection increased production of fractalkine by BAL cells from non-asthmatic controls (P<0.01) and in M1-polarised macrophages (P<0.05), but not in BAL cells from mild asthmatics or in M2 polarised macrophages. Rhinovirus induced fractalkine in PBMCs from asthmatic (P<0.001) and healthy control subjects (P<0.05). Trends towards induction of fractalkine in moderate asthmatic subjects during in vivo rhinovirus infection failed to reach statistical significance. Fractalkine may be involved in both immunopathological and anti-viral immune responses to rhinovirus infection. Further investigation into how fractalkine is regulated across different cell types and into the effect of stimulation including rhinovirus infection is warranted to better understand the precise role of this unique dual adhesion factor and chemokine in immune cell recruitment.

[1]  Daniel J. Jackson,et al.  Cadherin-related family member 3, a childhood asthma susceptibility gene product, mediates rhinovirus C binding and replication , 2015, Proceedings of the National Academy of Sciences.

[2]  Kenzie D. MacIsaac,et al.  Phenotypic Responses of Differentiated Asthmatic Human Airway Epithelial Cultures to Rhinovirus , 2015, PloS one.

[3]  S. Johnston,et al.  The role of macrophage IL-10/innate IFN interplay during virus-induced asthma , 2014, Reviews in medical virology.

[4]  N. Papadopoulos,et al.  IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. , 2014, American journal of respiratory and critical care medicine.

[5]  Andrew McKenzie,et al.  Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation , 2014, Science Translational Medicine.

[6]  C. Limatola,et al.  Modulating neurotoxicity through CX3CL1/CX3CR1 signaling , 2014, Front. Cell. Neurosci..

[7]  S. Johnston,et al.  Airway Inflammation and Illness Severity in Response to Experimental Rhinovirus Infection in Asthma , 2014, Chest.

[8]  D. Spandidos,et al.  Chemokines and atherosclerosis: focus on the CX3CL1/CX3CR1 pathway , 2013, Acta Pharmacologica Sinica.

[9]  D. Spandidos,et al.  Chemokines and atherosclerosis : focus on the CX 3 CL 1 / CX 3 CR 1 pathway , 2013 .

[10]  A. Gounni,et al.  The alveolar macrophages in asthma: a double-edged sword , 2012, Mucosal Immunology.

[11]  S. Johnston,et al.  Rhinovirus 16-induced IFN-α and IFN-β are deficient in bronchoalveolar lavage cells in asthmatic patients. , 2012, The Journal of allergy and clinical immunology.

[12]  S. Biswas,et al.  Macrophage polarization and plasticity in health and disease , 2012, Immunologic Research.

[13]  S. Johnston,et al.  Asthma exacerbations: Origin, effect, and prevention , 2011, Journal of Allergy and Clinical Immunology.

[14]  S. Johnston,et al.  The Role of IL-15 Deficiency in the Pathogenesis of Virus-Induced Asthma Exacerbations , 2011, PLoS pathogens.

[15]  M. Gavala,et al.  Rhinoviruses, allergic inflammation, and asthma , 2011, Immunological reviews.

[16]  S. Doggrell CXCR 1 is required for airway inflammation by promoting T helper cell survival and maintenance in inflamed lung , 2011 .

[17]  M. Beamer,et al.  Fractalkine/CX3CL1: a potential new target for inflammatory diseases. , 2010, Molecular interventions.

[18]  C. Weber,et al.  Requirements for leukocyte transmigration via the transmembrane chemokine CX3CL1 , 2010, Cellular and Molecular Life Sciences.

[19]  J. D'haese,et al.  Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential , 2010, Expert opinion on therapeutic targets.

[20]  I. Pavord,et al.  An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. , 2009, American journal of respiratory and critical care medicine.

[21]  S. Johnston,et al.  Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production , 2008, Proceedings of the National Academy of Sciences.

[22]  R. A. Killington,et al.  Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation , 2008, Nature Medicine.

[23]  Takahiro Shibata,et al.  Dose-Dependent Differential Regulation of Cytokine Secretion from Macrophages by Fractalkine1 , 2007, The Journal of Immunology.

[24]  Stephen T Holgate,et al.  Role of deficient type III interferon-λ production in asthma exacerbations , 2006, Nature Medicine.

[25]  J. Vernejoux,et al.  Fraktalkine Produced by Airway Smooth Muscle Cells Contributes to Mast Cell Recruitment in Asthma1 , 2006, The Journal of Immunology.

[26]  S. Johnston,et al.  Role of deficient type III interferon-lambda production in asthma exacerbations. , 2006, Nature medicine.

[27]  S. Johnston,et al.  Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus , 2005, The Journal of experimental medicine.

[28]  K. Chung,et al.  Fractalkine/CX3CL1 production by human airway smooth muscle cells: induction by IFN-γ and TNF-α and regulation by TGF-β and corticosteroids , 2004 .

[29]  K. Chung,et al.  Fractalkine/CX3CL1 production by human airway smooth muscle cells: induction by IFN-gamma and TNF-alpha and regulation by TGF-beta and corticosteroids. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[30]  S. Durham,et al.  The CX3C chemokine fractalkine in allergic asthma and rhinitis. , 2003, The Journal of allergy and clinical immunology.

[31]  R. Wood,et al.  FREQUENCY, SEVERITY, AND DURATION OF RHINOVIRUS INFECTIONS IN ASTHMATIC AND NONASTHMATIC INDIVIDUALS: A LONGITUDINAL COHORT STUDY , 2003, Pediatrics.

[32]  N. Papadopoulos,et al.  A defective type 1 response to rhinovirus in atopic asthma , 2002, Thorax.

[33]  Stephen T Holgate,et al.  Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study , 2002, The Lancet.

[34]  T. Imaizumi,et al.  Interferon-gamma stimulates fractalkine expression in human bronchial epithelial cells and regulates mononuclear cell adherence. , 2001, American journal of respiratory cell and molecular biology.

[35]  W. Busse,et al.  Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection. , 2000, American journal of respiratory and critical care medicine.

[36]  S. Johnston,et al.  Rhinovirus Infection Induces Expression of Its Own Receptor Intercellular Adhesion Molecule 1 (ICAM-1) via Increased NF-κB-mediated Transcription* , 1999, The Journal of Biological Chemistry.

[37]  J. Gliemann,et al.  Receptors of the low density lipoprotein (LDL) receptor family in man. Multiple functions of the large family members via interaction with complex ligands. , 1998, Biological chemistry.

[38]  T. Schall,et al.  Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and Adhesion , 1997, Cell.

[39]  Wei Wang,et al.  A new class of membrane-bound chemokine with a CX3C motif , 1997, Nature.